Magnetic Resonance Imaging and Spectroscopy of the Prostate

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Prostate Cancer

Treatments: Other: MRI and MRSI

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT00590993

00-136

Details and patient eligibility

About

Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.

Enrollment: 1,005 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• prostate cancer patients willing to undergo a MRI and MRSI exam

Exclusion criteria

• patients with prostate cancer and bone or lymph node metastasis
• patients who can not have an MRI exam

Trial design

1,005 participants in 1 patient group

1 - MRSI / MRI

Treatment:

Other: MRI and MRSI